Association of polymorphisms in the IL-18 and IL-12 genes with susceptibility to type 1 diabetes in Turkish patients

Journal of Endocrinological Investigation

Volumn 33, Issue 7, 2010, Pages 451-454

  Altinova, Alev E ^a   Engin, D ^a   Akbay, E ^b   Akturk, M ^a   Toruner, F ^a   Ersoy, R ^c   Yetkin, I ^a   Arslan, M ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b MERSIN UNIVERSITY   (Turkey)

^c ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Gene polymorphism; IL 12; IL 18; Type 1 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 18;

3' UNTRANSLATED REGION; ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TURKEY (BIRD);

ADOLESCENT; ADULT; AGE OF ONSET; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-18; MALE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; TURKEY;

EID: 77957285984     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/bf03346623     Document Type: Article

References (35)

1. Eisenbarth GS. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 1986, 314: 1360-8.
2. Bach JF. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 1994, 15: 516-42.
3. Achenbach P, Bonifacio E, Koczwara K, Ziegler AG. Natural history of type 1 diabetes. Diabetes 2005, 54 (Suppl 2): S25-31.
4. Horenstein RB, Shuldiner AR. Genetics of diabetes. Rev Endocr Metab Disord 2004, 5: 25-36.
5. Redondo MJ, Fain PR, Eisenbarth GS. Genetics of type 1A diabetes. Recent Prog Horm Res 2001, 56: 69-89.
6. Rabinovitch A. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab Rev 1998, 14: 129-51. (Pubitemid 28346261)
7. Almawi WY, Tamim H, Azar ST. Clinical review 103: T helper type 1 and 2 cytokines mediate the onset and progression of type I (insulin-dependent) diabetes. J Clin Endocrinol Metab 1999, 84: 1497-502.
8. Trembleau S, Penna G, Gregori S, Giarratana N, Adorini L. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma. J Immunol 2003, 170: 5491-501. (Pubitemid 36617837)
9. McInnes IB, Gracie JA, Leung BP, Wei XQ, Liew FY. Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol Today 2000, 21: 312-5.
10. Reddy P. Interleukin-18: recent advances. Curr Opin Hematol 2004, 11: 405-10.
11. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 2001, 12: 53-72.
12. Oikawa Y, Shimada A, Kasuga A, et al. Systemic administration of IL-18 promotes diabetes development in young nonobese diabetic mice. J Immunol 2003, 171: 5865-75.
13. Nicoletti F, Conget I, Di Marco R, et al. Serum levels of the interferon-gamma-inducing cytokine interleukin-18 are increased in individuals at high risk of developing type I diabetes. Diabetologia 2001, 44: 309-11.
14. Dong GP, Yu ZS, Liang L, Zou CC, Fu JF, Wang CL. IL-18 gene promoter -137C/G and -607C/A polymorphisms in Chinese Han children with type 1 diabetes mellitus. Int J Immunogenet 2007, 34: 75-9. (Pubitemid 46435095)
15. Mojtahedi Z, Naeimi S, Farjadian S, Omrani GR, Ghaderi A. Association of IL-18 promoter polymorphisms with predisposition to Type 1 diabetes. Diabet Med 2006, 23: 235-9.
16. Kretowski A, Mironczuk K, Karpinska A, et al. Interleukin-18 promoter polymorphisms in type 1 diabetes. Diabetes 2002, 51: 3347-9.
17. Novota P, Kolostova K, Pinterova D, et al. Interleukin IL-18 gene promoter polymorphisms in adult patients with type 1 diabetes mellitus and latent autoimmune diabetes in adults. Immunol Lett 2005, 96: 247-51.
18. Boraska V, Terzic J, Skrabic V, et al. NeuroD1 gene and interleukin-18 gene polymorphisms in type 1 diabetes in Dalmatian population of Southern Croatia. Croat Med J 2006, 47: 571-8.
19. Ide A, Kawasaki E, Abiru N, et al. Association of interieukin-18 gene promoter polymorphisms in type 1 diabetes and autoimmune thyroid disease. Ann NY Acad Sci 2003, 1005: 436-9.
20. Szeszko JS, Howson JM, Cooper JD, et al. Analysis of polymorphisms of the interleukin-18 gene in type 1 diabetes and Hardy-Weinberg equilibrium testing. Diabetes 2006, 55: 559-62.
21. Martin RJ, Savage DA, Carson DJ, Maxwell AP, Patterson CC. Interleukin 18 promoter polymorphisms are not strongly associated with type I diabetes in a UK population. Genes Immunol 2005, 6: 171-4.
22. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995, 13: 251-76.
23. Nitta Y, Kawamoto S, Tashiro F, et al. IL-12 plays a pathologic role at the inflammatory loci in the development of diabetes in NOD mice. Autoimmun 2001, 16: 97-104. (Pubitemid 32552984)
24. Trembleau S, Penna G, Bosi E, Mortara A, Gately MK, Adorini L. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 1995, 181: 817-21.
25. Windsor L, Morahan G, Huang D, et al. Alleles of the IL12B 3′UTR associate with late onset of type 1 diabetes. Hum Immunol 2004, 65: 1432-6.
26. Davoodi-Semiromi A, Yang JJ, She JX. IL-12p40 is associated with type 1 diabetes in Caucasian-American families. Diabetes 2002, 51: 2334-6.
27. Nistico L, Giorgi G, Giordano M, et al. IL12B polymorphism and type 1 diabetes in the Italian population: a case-control study. Diabetes 2002, 51: 1649-50.
28. McCormack RM, Maxwell AP, Carson DJ, Patterson CC, Middleton D, Savage DA. The IL12B 3′ untranslated region DNA polymorphism is not associated with early-onset type 1 diabetes. Genes Immunol 2002, 3: 433-5.
29. Johansson S, Lie BA, Thorsby E, Undlien DE. The polymorphism in the 3′ untranslated region of IL12B has a negligible effect on the susceptibility to develop type 1 diabetes in Norway. Immunogenetics 2001, 53: 603-5. (Pubitemid 33044441)
30. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2006, 29 (Suppl 1): S43-8.
31. Huang D, Cancilla MR, Morahan G. Complete primary structure, chromosomal localisation, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit. Genes Immunol 2000, 1: 515-20.
32. Ide A, Kawasaki E, Abiru N, et al. Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes. J Autoimmun 2004, 22: 73-8.
33. Yang JM, Nagasaka S, Yatagai T, et al. Interleukin-12p40 gene (IL-12B) polymorphism and Type 1 diabetes mellitus in Japanese: possible role in subjects without having high-risk HLA haplotypes. Diabetes Res Clin Pract 2006, 71: 164-9.
34. Sabbah E, Savola K, Ebeling T. Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes. Diabetes Care 2000, 23: 1326-32.
35. Altinova AE, Yetkin I, Akbay E, Bukan N, Arslan M. Serum IL-18 levels in patients with type 1 diabetes: Relations to metabolic control and microvascular complications. Cytokine 2008, 42: 217-21.